Ciro
Casanova Macario
Profesor Titular Universidad
![Foto de Ciro](/img/nophoto.png)
![Foto de Universidad de Navarra](/img/noimage_org.png)
Universidad de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Navarra (49)
2024
-
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15
2022
-
Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort
Respirology, Vol. 27, Núm. 4, pp. 286-293
2021
-
Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
Chest, Vol. 160, Núm. 3, pp. 872-878
-
Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex
Chest, Vol. 160, Núm. 2, pp. 481-490
-
Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers
Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12
-
Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539
2020
-
Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data
ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10
-
Somatotypes trajectories during adulthood and their association with copd phenotypes
ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9
2019
-
External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study
COPD: Journal of Chronic Obstructive Pulmonary Disease
-
Plasma metabolomics and clinical predictors of survival differences in COPD patients
Respiratory Research, Vol. 20, Núm. 1
2018
-
Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort
Chest, Vol. 154, Núm. 2, pp. 274-285
-
Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort
PLoS ONE, Vol. 13, Núm. 2
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease
BMC Medicine, Vol. 16, Núm. 1
-
Pulmonary arterial enlargement predicts long-term survival in COPD patients
PLoS ONE, Vol. 13, Núm. 4
-
Temporal transitions in COPD severity stages within the GOLD 2017 classification system
Respiratory Medicine, Vol. 142, pp. 81-85
2017
-
A simple algorithm for the identification of clinical COPD phenotypes
European Respiratory Journal, Vol. 50, Núm. 5
-
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
Archivos de Bronconeumologia, Vol. 53, Núm. 10, pp. 574-582
-
Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
The European respiratory journal, Vol. 50, Núm. 5
-
Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients
Respiratory Research, Vol. 18, Núm. 1